Unsuspected risk factors of frequent exacerbations requiring hospital admission in chronic obstructive pulmonary disease
暂无分享,去创建一个
E. Ozyilmaz | N. Kokturk | E Ozyilmaz | N Kokturk | G Teksut | T Tatlicioglu | T. Tatlicioglu | G. Teksut
[1] J E Cotes,et al. Lung volumes and forced ventilatory flows , 1993, European Respiratory Journal.
[2] F. Martinez,et al. Exacerbations of chronic obstructive pulmonary disease. , 2007, Proceedings of the American Thoracic Society.
[3] T. Similowski,et al. The potential impact of anaemia of chronic disease in COPD , 2006, European Respiratory Journal.
[4] B. Celli,et al. Exacerbations of chronic obstructive pulmonary disease , 2007, European Respiratory Journal.
[5] S. Frøland,et al. Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure. , 1999, Journal of the American College of Cardiology.
[6] J. Doyle,et al. Anemia in chronic obstructive pulmonary disease: epidemiology and economic implications. , 2008, Current medical research and opinion.
[7] A. Anzueto,et al. Impact of statins and ACE inhibitors on mortality after COPD exacerbations , 2009, Respiratory research.
[8] J. Wedzicha,et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. , 2010, The New England journal of medicine.
[9] K. Ohta,et al. Adherence to treatment by patients with asthma or COPD: comparison between inhaled drugs and transdermal patch. , 2007, Respiratory medicine.
[10] J A Anderson,et al. Adherence to inhaled therapy, mortality and hospital admission in COPD , 2009, Thorax.
[11] N. Nahman,et al. Role of gastroesophageal reflux symptoms in exacerbations of COPD. , 2006, Chest.
[12] M. Pearson,et al. Clinical audit indicators of outcome following admission to hospital with acute exacerbation of chronic obstructive pulmonary disease , 2002, Thorax.
[13] T. Seemungal,et al. COPD exacerbations: defining their cause and prevention , 2007, The Lancet.
[14] I. Stanopoulos,et al. Anemia of Chronic Disease in Chronic Obstructive Pulmonary Disease: A Case-Control Study of Cardiopulmonary Exercise Responses , 2011, Respiration.
[15] E. Silverman,et al. Clinical determinants of exacerbations in severe, early-onset COPD , 2007, European Respiratory Journal.
[16] T. Seemungal,et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease , 2002, Thorax.
[17] Nicolas Roche,et al. Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects. , 2009, Chest.
[18] G. Donaldson,et al. COPD exacerbations · 1: Epidemiology , 2006, Thorax.
[19] M. Etminan,et al. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease. , 2006, Journal of the American College of Cardiology.
[20] M. Cazzola,et al. Effect of enalapril on exercise cardiopulmonary performance in chronic obstructive pulmonary disease: A pilot study. , 2010, Pulmonary pharmacology & therapeutics.
[21] P. Paggiaro,et al. Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease , 1998, The Lancet.
[22] M. Miravitlles. Review: Do we need new antibiotics for treating exacerbations of COPD? , 2007, Therapeutic advances in respiratory disease.
[23] T. Seemungal,et al. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.
[24] J E Cotes,et al. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. , 1993, The European respiratory journal. Supplement.
[25] L. Goodnough,et al. Anemia of chronic disease. , 2005, The New England journal of medicine.
[26] Thomas Similowski,et al. Prognostic value of the hematocrit in patients with severe COPD receiving long-term oxygen therapy. , 2005, Chest.
[27] J. Soriano,et al. Prognosis of COPD patients requiring frequent hospitalization: role of airway infection. , 2010, Respiratory medicine.
[28] T. Seemungal,et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.
[29] B. Celli,et al. Predictors of Survival in COPD: more than just the FEV1. , 2008, Respiratory medicine.
[30] O. Keene,et al. Temporal clustering of exacerbations in chronic obstructive pulmonary disease. , 2010, American journal of respiratory and critical care medicine.
[31] R. Levy,et al. Risk factors and outcomes associated with chronic obstructive pulmonary disease exacerbations requiring hospitalization. , 2009, Canadian respiratory journal.
[32] E. Björnsson,et al. Prevalence of gastrointestinal symptoms in patients with chronic obstructive pulmonary disease , 2008, European journal of gastroenterology & hepatology.
[33] K. Kostikas,et al. Hemoglobin, erythropoietin and systemic inflammation in exacerbations of chronic obstructive pulmonary disease. , 2011, European journal of internal medicine.
[34] K. Savik,et al. High prevalence of proximal and distal gastroesophageal reflux disease in advanced COPD. , 2007, Chest.